Clinical Trial Update: Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating peposertib in combination with capecitabine and radiotherapy in locally advanced rectal cancer has completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Peposertib (Peposertib)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Locally Advanced Rectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-07-07